Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million

Bulletin Express

Oct 28

Alphamab Oncology (09966) disclosed that on 28 October 2025, 320,000 ordinary shares were repurchased on the Hong Kong Stock Exchange. The highest repurchase price per share reached HKD 11.97, with the lowest at HKD 11.53, amounting to an aggregate paid sum of approximately HKD 3.77 million.

After this repurchase, the number of issued shares (excluding treasury shares) decreased to 970,074,697, while treasury shares increased to 4,073,000. The overall total of issued shares remained at 974,147,697. The repurchase was carried out under a mandate granted on 12 June 2025, which authorized the repurchase of up to 96,218,980 shares. Cumulatively, the company has repurchased 1,121,000 shares under this authority, representing around 0.1165% of the issued shares (excluding treasury shares) at the time the mandate was granted.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1147986574"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147986574\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147986574?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 22:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147986574","market":"us","top_or_hot":-1,"title":"Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million","media":"Bulletin Express","content":"<p>Alphamab Oncology (09966) disclosed that on 28 October 2025, 320,000 ordinary shares were repurchased on the Hong Kong Stock Exchange. The highest repurchase price per share reached HKD 11.97, with the lowest at HKD 11.53, amounting to an aggregate paid sum of approximately HKD 3.77 million.</p>\n<p>After this repurchase, the number of issued shares (excluding treasury shares) decreased to 970,074,697, while treasury shares increased to 4,073,000. The overall total of issued shares remained at 974,147,697. The repurchase was carried out under a mandate granted on 12 June 2025, which authorized the repurchase of up to 96,218,980 shares. Cumulatively, the company has repurchased 1,121,000 shares under this authority, representing around 0.1165% of the issued shares (excluding treasury shares) at the time the mandate was granted.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-28 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alphamab Oncology (09966) disclosed that on 28 October 2025, 320,000 ordinary shares were repurchased on the Hong Kong Stock Exchange. The highest repurchase price per share reached HKD 11.97, with the lowest at HKD 11.53, amounting to an aggregate paid sum of approximately HKD 3.77 million.</p>\n<p>After this repurchase, the number of issued shares (excluding treasury shares) decreased to 970,074,697, while treasury shares increased to 4,073,000. The overall total of issued shares remained at 974,147,697. The repurchase was carried out under a mandate granted on 12 June 2025, which authorized the repurchase of up to 96,218,980 shares. Cumulatively, the company has repurchased 1,121,000 shares under this authority, representing around 0.1165% of the issued shares (excluding treasury shares) at the time the mandate was granted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09966","symbol_name":"康宁杰瑞制药-B","start_time":0,"source_url":"","article_id":"1147986574","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147986574","pubTimestamp":1761661598,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Alphamab Oncology (09966) disclosed that on 28 October 2025, 320,000 ordinary shares were repurchased on the Hong Kong Stock Exchange. The highest repurchase price per share reached HKD 11.97, with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09966":"康宁杰瑞制药-B"},"translate_title":"康宁杰瑞(09966)公布回购股份合共377万港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09966":1},"content_text":"Alphamab Oncology (09966) disclosed that on 28 October 2025, 320,000 ordinary shares were repurchased on the Hong Kong Stock Exchange. The highest repurchase price per share reached HKD 11.97, with the lowest at HKD 11.53, amounting to an aggregate paid sum of approximately HKD 3.77 million.\nAfter this repurchase, the number of issued shares (excluding treasury shares) decreased to 970,074,697, while treasury shares increased to 4,073,000. The overall total of issued shares remained at 974,147,697. The repurchase was carried out under a mandate granted on 12 June 2025, which authorized the repurchase of up to 96,218,980 shares. Cumulatively, the company has repurchased 1,121,000 shares under this authority, representing around 0.1165% of the issued shares (excluding treasury shares) at the time the mandate was granted.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}